malondialdehyde has been researched along with g(m3) ganglioside in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ao, M; Chen, G; Chen, Y; Huang, J; Liao, H; Shao, W; Sun, Y; Wang, K; Wang, Z; Wei, B; Zeng, S; Zhou, X; Zhou, Y | 1 |
1 other study(ies) available for malondialdehyde and g(m3) ganglioside
| Article | Year |
|---|---|
Exogenous GM3 ganglioside inhibits atherosclerosis via multiple steps: A potential atheroprotective drug.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cell Line; Endothelial Cells; G(M3) Ganglioside; Human Umbilical Vein Endothelial Cells; Humans; Lipoproteins, LDL; Macrophages; Malondialdehyde; Mice; Monocytes; Oxidation-Reduction; Plaque, Atherosclerotic; RAW 264.7 Cells | 2019 |